Stefan Peinert

902 total citations
21 papers, 357 citations indexed

About

Stefan Peinert is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Stefan Peinert has authored 21 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in Stefan Peinert's work include CAR-T cell therapy research (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Immune Cell Function and Interaction (5 papers). Stefan Peinert is often cited by papers focused on CAR-T cell therapy research (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Immune Cell Function and Interaction (5 papers). Stefan Peinert collaborates with scholars based in Australia, Germany and United States. Stefan Peinert's co-authors include H. Miles Prince, Mark J. Smyth, Joseph A. Trapani, Phillip K. Darcy, Michael H. Kershaw, David Ritchie, Simon J. Harrison, Paul J. Neeson, Dirk Hönemann and Andrew M. Scott and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Cancer.

In The Last Decade

Stefan Peinert

21 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Peinert Australia 11 254 170 108 86 64 21 357
Antonio Valeri Spain 12 294 1.2× 124 0.7× 303 2.8× 60 0.7× 96 1.5× 23 462
Sabarinath Venniyil Radhakrishnan United States 12 219 0.9× 119 0.7× 112 1.0× 38 0.4× 128 2.0× 28 332
Kevin M. Friedman United States 8 405 1.6× 193 1.1× 283 2.6× 55 0.6× 67 1.0× 15 530
Wenjie Gong China 11 214 0.8× 107 0.6× 95 0.9× 57 0.7× 31 0.5× 22 324
Liufang Gu China 9 192 0.8× 142 0.8× 92 0.9× 31 0.4× 108 1.7× 22 371
Rawan Faramand United States 10 210 0.8× 154 0.9× 57 0.5× 59 0.7× 115 1.8× 37 375
Liora M. Schultz United States 10 347 1.4× 132 0.8× 202 1.9× 77 0.9× 50 0.8× 41 455
Aygul Valiullina Russia 10 259 1.0× 170 1.0× 148 1.4× 69 0.8× 19 0.3× 17 412
Dirk Hönemann Australia 9 314 1.2× 202 1.2× 227 2.1× 112 1.3× 121 1.9× 13 511
Nawid Albinger Germany 6 279 1.1× 107 0.6× 212 2.0× 57 0.7× 49 0.8× 9 349

Countries citing papers authored by Stefan Peinert

Since Specialization
Citations

This map shows the geographic impact of Stefan Peinert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Peinert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Peinert more than expected).

Fields of papers citing papers by Stefan Peinert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Peinert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Peinert. The network helps show where Stefan Peinert may publish in the future.

Co-authorship network of co-authors of Stefan Peinert

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Peinert. A scholar is included among the top collaborators of Stefan Peinert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Peinert. Stefan Peinert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peinert, Stefan, Constantine S. Tam, H. Miles Prince, et al.. (2010). Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia. Leukemia & lymphoma. 51(12). 2188–2197. 12 indexed citations
2.
Neeson, Paul J., Kellie M. Tainton, H. Miles Prince, et al.. (2010). Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype. Gene Therapy. 17(9). 1105–1116. 36 indexed citations
3.
Peinert, Stefan, H. Miles Prince, Michael H. Kershaw, et al.. (2010). Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen. Gene Therapy. 17(5). 678–686. 98 indexed citations
4.
Stein, Alexander, et al.. (2010). The role of peri-operative treatment in resectable liver metastases of colorectal cancer. Therapeutic Advances in Medical Oncology. 2(6). 389–398. 2 indexed citations
5.
Peinert, Stefan, Constantine S. Tam, M Wolf, et al.. (2009). FLUDARABINE BASED COMBINATION THERAPY IS HIGHLY ACTIVE AS PRIMARY OR SALVAGE TREATMENT IN PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA. 94. 1 indexed citations
6.
Peinert, Stefan, Margaret F. Moloney, H. Miles Prince, et al.. (2009). RAPID INFUSION OF RITUXIMAB IS WELL TOLERATED AND ENABLES MORE EFFICIENT USE OF HAEMATOLOGY DAY WARD RESOURCES. 94. 2 indexed citations
7.
Westwood, Jennifer A., William K. Murray, Melanie Trivett, et al.. (2009). The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum. Journal of Immunotherapy. 32(3). 292–301. 56 indexed citations
8.
Peinert, Stefan, H. Miles Prince, & Simon J. Harrison. (2008). The development of novel immunotherapeutic approaches in multiple myeloma. Leukemia & lymphoma. 49(4). 652–654. 1 indexed citations
9.
Peinert, Stefan & John F. Seymour. (2008). Indolent Lymphomas Other than Follicular and Marginal Zone Lymphomas. Hematology/Oncology Clinics of North America. 22(5). 903–940. 4 indexed citations
10.
Westwood, Jennifer A., William K. Murray, Paul J. Neeson, et al.. (2008). Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice. Gene Therapy. 15(14). 1056–1066. 20 indexed citations
11.
Peinert, Stefan, David Ritchie, Simon J. Harrison, et al.. (2008). Targeting Lewis Y-Positive Multiple Myeloma and Acute Myeloid Leukemia with Gene-Modified T Cells Demonstrating Memory Phenotype. Blood. 112(11). 3900–3900. 3 indexed citations
12.
Peinert, Stefan, Constantine S. Tam, H. Miles Prince, et al.. (2008). Fludarabine Based Combinations Are Highly Effective as First-Line or Salvage Treatment in Patients with Waldenstrom Macroglobulinemia. Blood. 112(11). 4947–4947. 1 indexed citations
13.
14.
15.
Arnold, Dirk, Stefan Peinert, Wieland Voigt, & Hans‐Joachim Schmoll. (2006). Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Present and Future Role in Gastrointestinal Cancer Treatment: A Review. The Oncologist. 11(6). 602–611. 25 indexed citations
16.
Peinert, Stefan, et al.. (2006). BECAM: A salvage protocol with bevacizumab, capecitabin, and mitomycin C for patients with refractory metastatic colorectal cancer (CRC) or gastric cancer (GC). Journal of Clinical Oncology. 24(18_suppl). 13554–13554. 2 indexed citations
17.
Grothe, Wilfried, et al.. (2005). Cetuximab with oxaliplatin and capecitabine (CAPOX)in patients with metastatic colorectal cancer (mCRC) refractory to standard chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 3669–3669. 11 indexed citations
18.
Peinert, Stefan, Wilfried Grothe, Karin Jordan, et al.. (2005). Weekly administration of 5-fluorouracil (5-FU), folinic acid (FA), oxaliplatin (L-OHP) and irinotecan (CPT-11) [FUFOXIRI] for patients with metastatic gastric or colorectal cancer. Journal of Clinical Oncology. 23(16_suppl). 3719–3719. 2 indexed citations
19.
Carpinteiro, Alexander, Stefan Peinert, Wolfram Ostertag, et al.. (2002). Genetic protection of repopulating hematopoietic cells with an improved MDR1‐retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice. International Journal of Cancer. 98(5). 785–792. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Valeri Breakdown of academic impact, for papers by Sabarinath Venniyil Radhakrishnan Breakdown of academic impact, for papers by Kevin M. Friedman Breakdown of academic impact, for papers by Wenjie Gong Breakdown of academic impact, for papers by Liufang Gu Breakdown of academic impact, for papers by Rawan Faramand Breakdown of academic impact, for papers by Liora M. Schultz Breakdown of academic impact, for papers by Aygul Valiullina Breakdown of academic impact, for papers by Dirk Hönemann Breakdown of academic impact, for papers by Nawid Albinger
Rankless by CCL
2026